Emerging Markets Series: The Pharmaceutical Market of Poland

Table of Contents

EXECUTIVE SUMMARY

• Scope
• Key findings
• Related reports

DEMOGRAPHIC TRENDS IN POLAND

• Key findings
• Socio and business demographics of Poland
  • Poland is politically stable
  • The introduction of Special Economic Zones offer a major incentive for foreign investment
  • Low corporation income tax is an incentive for foreign investment in Poland
  • Polish international trade largely confined to the EU

THE HEALTHCARE SYSTEM IN POLAND

• Key findings
• The healthcare system in Poland
  • Healthcare expenditure in Poland
• Polish healthcare system is in need of reform
  • Hospital debt and corruption are crippling the public healthcare system
  • Polish regulatory landscape
  • Polish pharmaceutical industry legislation
• Pricing and Reimbursement system in Poland lacks consistency
  • Pricing controls in Poland
  • Reimbursement controls in Poland

POLISH PHARMACEUTICAL MARKET

• Key findings
• Polish pharmaceutical market is growing rapidly
  • Polish retail market is growing rapidly in value
  • Poland' s hospital pharmaceutical market is growing steadily
  • Top pharmaceutical players in Poland are all international companies
  • Generic players dominate Poland' s pharmaceutical market
  • Polish patent and intellectual property law in desperate need of reform

BIBLIOGRAPHY

• Publications and online articles

APPENDIX

• Exchange rates

TABLES

• Table: Poland: health demographics, 2002 - 06
• Table: Poland:, World Health Organization (WHO) core health indicators for healthcare expenditure, 2005
• Table: Poland: sales for the top ATC groups in the retail pharmaceutical market, 2005 - 08
• Table: Poland: top 12 brands in the retail pharmaceutical market, 2005 - 2008
• Table: Poland: top 12 brands in the hospital pharmaceutical market, 2005 - 2008
• Table: Poland: sales for the top ATC groups in hospital pharmaceutical market, 2005 - 08
• Table: Poland: top 10 drug manufacturing companies, 2007 - 08
• Table: Poland: top 10 generic pharmaceutical companies, 2008
• Table: Exchange rates, 2008

FIGURES

• Figure: Drivers and resistors to investing in Poland
• Figure: Poland: scientific and innovative indicators, 2009
• Figure: SWOT analysis of the Polish biotechnology market, 2008
• Figure: Poland: population estimates, 1980 - 2050
• Figure: Poland: value of private healthcare market (PLN billion), 2 005 - 10
• Figure: Poland: healthcare system network, 2009
• Figure: Poland: combined total drug sales, 2005 - 08
• Figure: Poland: value and volume sales for the retail pharmaceutical market, 2005 - 08
• Figure: Poland: top ATC groups in the retail pharmaceutical market, 2005 - 07
• Figure: Poland: sales for the top ATC groups in the hospital pharmaceutical market, 2007